Efficacy and safety of tocilizumab in critically ill adults with COVID-19 infection in Bahrain: A report of 5 cases
oleh: Mohamed M ElSeirafi, Hasan MSN Hasan, Kannan Sridharan, Alaa Zamoori, Sana Alkhawaja, Sheikh Abdul Azeez Pasha
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2020-01-01 |
Deskripsi
Tocilizumab has been recognized as one of the few existing biologic useful for combating COVID-19 infections especially in critically ill patient. We had experience in treating five critically ill patients with severe lung injury who were COVID-19 positive with tocilizumab. In the present case series, we have attempted to summarize their clinical profile, changes in laboratory biomarkers and outcomes.